INTARCIA THERAPEUTICS

intarcia-therapeutics-logo

Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

#SimilarOrganizations #People #Financial #Website #More

INTARCIA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical Device Personal Health

Founded:
1997-01-01

Address:
Hayward, California, United States

Country:
United States

Website Url:
http://www.intarcia.com

Total Employee:
251+

Status:
Active

Contact:
617-936-2500

Email Addresses:
[email protected]

Total Funding:
1.68 B USD

Technology used in webpage:
Domain Not Resolving Euro IPv6 Amazon Route 53 Microsoft Apple Whitelist


Similar Organizations

advanced-animal-diagnostics-logo

Advanced Animal Diagnostics

Advanced Animal Diagnostics develops diagnostic products to cure on-farm animal diseases.

aerin-medical-logo

Aerin Medical

Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

alcresta-logo

Alcresta

Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.

american-renal-associates-holdings-logo

American Renal Associates Holdings

American Renal Associates Holdings operates kidney dialysis services and offers outpatient and inpatient dialysis treatments.

ancora-heart-logo

Ancora Heart

Ancora Heart is dedicated to helping people with heart failure feel better and live longer.

spaceoar-logo

SpaceOAR

SpaceOAR is a medical device company that develops space-filling hydrogels for radiation oncology and cancer surgery indications.

binx-health-logo

Binx Health

Binx Health creates new categories of healthcare solutions that deliver on-demand testing to people where they need it most.

butterfly-network-logo

Butterfly Network

Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

daktari-diagnostics-logo

Daktari Diagnostics

Daktari Diagnostics manufactures diagnostic medical products for clinicians and patients.

elcelyx-therapeutics-logo

Elcelyx Therapeutics

Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.

enzium-logo

Enzium

Enzium develops fluorescent based reagents for selective protease.

galera-therapeutics-logo

Galera Therapeutics

Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.

forward-logo

Forward

Forward is a healthcare startup that provides a membership-based health care system.

humacyte-logo

Humacyte

Humacyte develops products for vascular diseases and replacement of anatomical conduits.

imaginab-logo

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

not_available_image

Impliant

Impliant, Inc. develops novel spine arthroplasty solutions for motion preservation. The company offers TOPS system.

injectsense-logo

Injectsense

Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.

ipierian-logo

iPierian

iPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s.

ivantis-logo

Ivantis

Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.

jcyte-logo

jCyte

jCyte is a developer of cell-based technology intended to cure retinitis pigmentosa.

moximed-logo

Moximed

Moximed improves the standard of care for patients with osteoarthritis and investigates therapies to treat affected joints.

opus-genetics-logo

Opus Genetics

Opus Genetics is a gene therapy company for ultra-rare blinding conditions.

oxford-immunotec-logo

Oxford Immunotec

Oxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology.

oxsonics-therapeutics-logo

OxSonics Therapeutics

OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®

prima-temp-logo

Prima Temp

Prima Temp specializes in fertility detection, early disease detection, and circadian rhythm monitoring.

amelia-virtual-care-logo

Amelia Virtual Care

Amelia Virtual Care develops a virtual reality platform designed to bring value to mental health treatment.

cardiacsense-logo

CardiacSense

CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and non-inflating blood pressure monitoring

syndevrx-logo

Syndevrx

SynDevRx develops polymer-based drug conjugates for small molecule drug activity.

ue-lifesciences-logo

UE LifeSciences

UE LifeSciences is a female technology company building preventive oncology solutions for primary care and home.

unicycive-therapeutics-logo

Unicycive Therapeutics

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs.

aspira-womens-health-logo

Aspira Women's Health

Aspira Women's Health develops and commercializes diagnostic tests that address unmet needs in gynecologic oncology and women’s health.

know-labs-logo

Know Labs

Know Labs is a non-invasive diagnostic technology platform that uses radio waves to identify and measure molecules in the body.

vivos-therapeutics-logo

Vivos Therapeutics

Vivos Therapeutics is a research and development company providing training for health care allowing to integrate breathing wellness.


Current Advisors List

nancy-thornberry_image

Nancy Thornberry Board Member @ Intarcia Therapeutics
Board_member
2013-12-01

gino-santini_image

Gino Santini Board Member @ Intarcia Therapeutics
Board_member
2013-06-01

bryan-roberts_image

Bryan Roberts Board Member @ Intarcia Therapeutics
Board_member
2003-06-01

jim-rosenthal_image

Jim Rosenthal Board Member @ Intarcia Therapeutics
Board_member
2017-09-19

kurt-graves_image

Kurt Graves Board Chairman @ Intarcia Therapeutics
Board_member
2010-08-01

patrick-conway_image

Patrick Conway Board Member @ Intarcia Therapeutics
Board_member
2017-09-19

bob-kerrey_image

Bob Kerrey Board Member @ Intarcia Therapeutics
Board_member
2017-09-19

jay-skyler_image

Jay Skyler Board Member @ Intarcia Therapeutics
Board_member
2017-09-19

Current Employees Featured

thomas-alessi_image

Thomas Alessi
Thomas Alessi Vice President, Development and Manufacturing @ Intarcia Therapeutics
Vice President, Development and Manufacturing
1997-12-01

david-franklin_image

David Franklin
David Franklin Vice President, Commercial Operations @ Intarcia Therapeutics
Vice President, Commercial Operations
2015-05-01

sunita-zalani_image

Sunita Zalani
Sunita Zalani Vice President, Global Regulatory Affairs and Quality @ Intarcia Therapeutics
Vice President, Global Regulatory Affairs and Quality
2014-05-01

andrew-young_image

Andrew Young
Andrew Young Vice President & Chief Scientific Officer @ Intarcia Therapeutics
Vice President & Chief Scientific Officer
2015-09-01

owen-hughes-jr_image

Owen Hughes, Jr
Owen Hughes, Jr Chief Business Officer and Head of Corporate Development @ Intarcia Therapeutics
Chief Business Officer and Head of Corporate Development
2013-02-01

jay-smith_image

Jay Smith
Jay Smith CXO- Chief Experience Officer- Head of Customer experience and Outcomes @ Intarcia Therapeutics
CXO- Chief Experience Officer- Head of Customer experience and Outcomes
2013-12-01

not_available_image

Dick Ford
Dick Ford Executive Director, DUROS® Manufacturing @ Intarcia Therapeutics
Executive Director, DUROS® Manufacturing
2006-08-01

fred-t-fiedorek_image

Fred T. Fiedorek
Fred T. Fiedorek Chief Medical Officer and Global Head of Regulatory Affair @ Intarcia Therapeutics
Chief Medical Officer and Global Head of Regulatory Affair

kurt-graves_image

Kurt Graves
Kurt Graves President & CEO @ Intarcia Therapeutics
President & CEO
2010-08-01

david-spellman_image

David Spellman
David Spellman Chief Financial & Chief Business Officer @ Intarcia Therapeutics
Chief Financial & Chief Business Officer
2019-11-01

Founder


david-franklin_image

David Franklin

james-m-ahlers_image

James M. Ahlers

thomas-alessi_image

Thomas Alessi

Acquisitions List

Date Company Article Price
2015-09-24 Phoundry Pharmaceuticals Phoundry Pharmaceuticals acquired by Intarcia Therapeutics N/A

Investors List

ggv-capital_image

GGV Capital

GGV Capital investment in Venture Round - Intarcia Therapeutics

sharespost-investment-management_image

SharesPost Investment Management

SharesPost Investment Management investment in Secondary Market - Intarcia Therapeutics

gwc-innovator-fund_image

GWC Innovator Fund

GWC Innovator Fund investment in Series E - Intarcia Therapeutics

bill-melinda-gates-foundation_image

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation investment in Series E - Intarcia Therapeutics

the-pritzker-organization_image

The Pritzker Organization

The Pritzker Organization investment in Series E - Intarcia Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series E - Intarcia Therapeutics

the-baupost-group_image

The Baupost Group

The Baupost Group investment in Series E - Intarcia Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series E - Intarcia Therapeutics

baillie-gifford_image

Baillie Gifford

Baillie Gifford investment in Series E - Intarcia Therapeutics

kayon-partners_image

Kayon Partners

Kayon Partners investment in Series E - Intarcia Therapeutics

Official Site Inspections

http://www.intarcia.com

  • Host name: ec2-18-208-125-27.compute-1.amazonaws.com
  • IP address: 18.208.125.27
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Intarcia Therapeutics" on Search Engine